Thomas Hubka has spent 12 years with Histogen focusing on business development, finance and operations. He works closely with all facets of the Company to ensure corporate budgeting and forecasting, and has been integral to development of the Company’s cost accounting policies.
Thomas, has spent 9 years with Histogen focusing on business development, finance and operations. He works closely with all facets of the Company to ensure corporate budgeting and forecasting and has been integral to development of the Company’s cost accounting policies. He develops strategic plans involving the in-licensing or out-licensing of technologies, as well as strategic alliances with pharmaceutical or device companies. He works with all department heads to develop efficient business models and effective costing in preclinical R&D, manufacturing, and clinical teams for trial costs and analysis, as well as coordinating budgets with the joint venture partners. With a bachelor’s degree in Business Management from Washington and Lee University and a focus on finance and marketing, Thomas brings a strong business management background to Histogen. Previously, Thomas worked in commercial real estate as part of a land and investment team at NAI Austin, managing investor relations, strategy and overseeing land development plans.
Current role